These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 6290066

  • 1. Clinical pharmacokinetics of cefotaxime and penetration in sputum, bone, and prostatic tissue.
    Braga PC, Pozzato C, Cedrini C, Fraschini F, Scarpazza G, Scaglione F, Gagliardi V, Apicella F, Manganelli V, Paiola G.
    Clin Ther; 1982; 5(1):69-78. PubMed ID: 6290066
    [Abstract] [Full Text] [Related]

  • 2. Cefoperazone pharmacokinetics and sputum levels after single/multiple i.m. injections in bronchopneumopathic patients and bone, pulmonary and prostatic tissue penetration.
    Braga PC, Scaglione F, Villa S, Scarpazza G, Gagliardi V, Biella G, Manganelli V, Paiola G, Fraschini F.
    Int J Clin Pharmacol Res; 1983; 3(5):349-55. PubMed ID: 6678828
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E, Morel C, Pierre J, Monrocq N, Dournovo P, Benard Y.
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [Abstract] [Full Text] [Related]

  • 5. Doses of antibiotic in patients with renal insufficiency.
    Ohkawa M, Kuroda K.
    Clin Ther; 1981 Jun; 4 Suppl A():124-32. PubMed ID: 6275994
    [Abstract] [Full Text] [Related]

  • 6. [Study on the prostatic tissue levels of cefmenoxime (CMX)].
    Kataoka K, Kaneko S, Kurita T.
    Hinyokika Kiyo; 1985 Feb; 31(2):273-9. PubMed ID: 2409786
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacokinetics of cefotaxime and desacetylcefotaxime in the blood serum and bronchial secretion in patients with chronic bronchitis after administration of a single 24-hour dose].
    Kamnev IuV, Manuĭlov KK, Orlov VA, Sokolova VI.
    Antibiot Khimioter; 1991 Oct; 36(10):42-4. PubMed ID: 1805696
    [Abstract] [Full Text] [Related]

  • 8. [A study of prostatic tissue levels of ceftizoxime, cefoperazone and cefotaxime].
    Ikeda S, Ishibashi A, Koshiba K.
    Hinyokika Kiyo; 1984 Aug; 30(8):1135-42. PubMed ID: 6083722
    [Abstract] [Full Text] [Related]

  • 9. [Passage of cefotiam into prostatic tissue].
    Charton M, Panis G, Brisset JM, Veillon B, Vallancien G, Selles JP.
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):530-2. PubMed ID: 3911149
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Limiting cefotaxime pediatric dosing to adult standards: a pharmacokinetic simulation study.
    Dulaney Lopez AM, Rodriguez JC, Lopez-Samblas AM, Estes KS.
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):269-74. PubMed ID: 10395117
    [Abstract] [Full Text] [Related]

  • 13. [Availability of cefotaxime. Pharmacokinetic studies on the distribution in central and various peripheral compartments (author's transl)].
    Wittmann DH, Schassan HH, Welter J, Seidel H.
    MMW Munch Med Wochenschr; 1980 Apr 25; 122(17):637-41. PubMed ID: 6248774
    [Abstract] [Full Text] [Related]

  • 14. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W, Harnisch L, Zimmer M, Rokitta C, Mendes P.
    Int J Clin Pharmacol Ther; 1995 Oct 25; 33(10):560-4. PubMed ID: 8574507
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Penetration of cefotaxime into bronchial secretions.
    Bergogne-Berezin E, Morel C, Pierre J, Monrocq N, Dournovo P, Benard Y.
    Rev Infect Dis; 1982 Oct 25; 4 Suppl():S392-5. PubMed ID: 6294788
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of ceftizoxime in patients undergoing hemodialysis.
    Shah PM, Knobloch M, Haag R, Kühnle HF.
    Methods Find Exp Clin Pharmacol; 1982 Oct 25; 4(3):185-8. PubMed ID: 6289027
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB, Dowell JA, Pratt RD.
    Clin Ther; 2007 Jul 25; 29(7):1368-80. PubMed ID: 17825688
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.